# Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)

> **NCT00575796** · PHASE2 · UNKNOWN · sponsor: **The Hospital for Sick Children** · enrollment: 50 (estimated)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** Vinblastine Sulphate

## Key facts

- **NCT ID:** NCT00575796
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-10
- **Primary completion:** 2018-10
- **Final completion:** 2019-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-09-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00575796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00575796, "Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00575796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*